Medical Developments International

Medical Developments International EBIT Margin

The EBIT Margin (Operating Margin) of Medical Developments International (MVP.AX) as of Oct 8, 2026 is 2.48 %. In the previous year, EBIT Margin (Operating Margin) was 7.87 % — a change of -68.44% (lower).

EBIT Margin

2.48 %

YoY

-68.44%

Last updated:

EBIT Margin (Operating Margin) of Medical Developments International is 2026 2.48 % . EBIT Margin (Operating Margin) of Medical Developments International was 2025 7.87 % . It decreases by -68.44% lower compared to the previous year.

For Medical Developments International, the operating (EBIT) margin of 2.5% is up versus -72.2% a few years ago.

The Medical Developments International EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
15.20 AUD
Jan 1, 2020
1.93 AUD
Jan 1, 2021
-20.73 AUD
Jan 1, 2022
-72.23 AUD
Jan 1, 2023
-63.22 AUD
Jan 1, 2024
-50.88 AUD
Jan 1, 2025
7.87 AUD
Jan 1, 2026
2.48 AUD
The Medical Developments International EBIT Margin history
YEAREBIT MarginYoY
2.48 %-68.44%
7.87 %-115.46%
-50.88 %-19.51%
-63.22 %-12.48%
-72.23 %+248.44%
-20.73 %-1,173.93%
1.93 %-87.30%
15.20 %+501.80%
2.53 %-86.76%
19.08 %-16.98%
22.98 %-9.00%
25.26 %+38.40%
18.25 %+5,567.66%
0.32 %+14.23%
0.28 %+52.79%
0.18 %+77.36%
0.10 %+26.62%
0.08 %-16.95%
0.10 %-51.71%
0.20 %—
Access this data via the Eulerpool API
Get Free API Key

Medical Developments International Stock analysis

What does Medical Developments International do? Medical Developments International Ltd is an Australian company specializing in the development and production of medical devices and products. The company was founded in 1971 by renowned researcher and entrepreneur Mark Sullivan and has since received numerous awards and accolades. The company's business model is based on the manufacture of emergency medical devices and products of the highest quality and effectiveness. It has three main business segments: Pharmaceuticals, Medical devices, and Animal health. Medical Developments International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medical Developments International stock

EBIT Margin (Operating Margin) of Medical Developments International is 2.48 % in 2026.

EBIT Margin (Operating Margin) of Medical Developments International changed from 7.87 % to 2.48 %, representing a -68.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Medical Developments International since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Medical Developments International with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API
Get Free API Key

Margins — Medical Developments International

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Medical Developments International